r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

HH

Howard Horn

Insider · Chief Financial Officer · RARE

Howard Horn files insider transactions with the SEC as a chief financial officer of Ultragenyx Pharmaceutical (RARE). We hold 9 disclosed purchases and sales filed since 11 October 2019, 2 of them in the last 90 days.

  • Files forRARE
  • Disclosed buys and sells9 in all, 2 in the last 90 days
  • Last disclosure4 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 9 October 2023 — 3 August 2026Chief Financial Officer · Ultragenyx Pharmaceutical (RARE)29 Form 4 lines · source: SEC Form 4
  • Filed 10 October 2019 — 23 February 2023CFO · Vir Biotechnology (VIR)18 Form 4 lines · source: SEC Form 4

Everything they disclosed

47 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.